Alpha 2.0
Login Register
» Articles » PMID: 21438098

Failure of Anakinra Treatment of Pyoderma Gangrenosum in an IBD Patient and Relevance to the PSTPIP1 Gene

Overview
Journal Inflamm Bowel Dis
Publisher Oxford University Press
Specialty Gastroenterology
Date 2011 Mar 26
PMID 21438098
Citations 8
Authors
Zhenwu Lin
John P Hegarty
Tony Lin
Barbara Ostrov
Yunhua Wang
Wei Yu
Ashley A Kelly
Lisa S Poritz
Walter A Koltun
Affiliations
Soon will be listed here.
Citing Articles

Effects of immune cells in mediating the relationship between inflammatory bowel disease and pyoderma gangrenosum: a two-sample, two-step mendelian randomization study.

Zhu H, Pan J Arch Dermatol Res. 2025; 317(1):176.

PMID: 39760889 DOI: 10.1007/s00403-024-03736-0.

Off-label use of anti-IL-1 drugs in rheumatic diseases.

Stefania S, Colia R, Cinzia R, Corrado A, Cantatore F Int J Immunopathol Pharmacol. 2021; 35:20587384211006584.

PMID: 33855881 PMC: 8056561. DOI: 10.1177/20587384211006584.

Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Ben Abdallah H, Fogh K, Bech R Int Wound J. 2019; 16(2):511-521.

PMID: 30604927 PMC: 7949186. DOI: 10.1111/iwj.13067.

Refractory Peristomal Pyoderma Gangrenosum Successfully Treated With Intravenous Immunoglobulin: A Case Report.

McAllister B, Williams E, Yoo L, Tinsley A, Koltun W, Ardell C Am J Gastroenterol. 2015; 110(12):1739-40.

PMID: 26673510 DOI: 10.1038/ajg.2015.344.

Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients.

Weizman A, Huang B, Berel D, Targan S, Dubinsky M, Fleshner P Inflamm Bowel Dis. 2014; 20(3):525-33.

PMID: 24487271 PMC: 4046633. DOI: 10.1097/01.MIB.0000442011.60285.68.